Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,433 | 297 | 98.8% |
| Education | $67.00 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,172 | 126 | $0 (2024) |
| PFIZER INC. | $604.17 | 28 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $393.91 | 30 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $279.92 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $243.26 | 9 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $218.53 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $210.47 | 13 | $0 (2024) |
| GENZYME CORPORATION | $194.30 | 7 | $0 (2024) |
| Celgene Corporation | $167.50 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $108.36 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,922 | 109 | ABBVIE INC. ($462.33) |
| 2023 | $1,399 | 69 | ABBVIE INC. ($622.70) |
| 2022 | $856.54 | 44 | ABBVIE INC. ($497.52) |
| 2021 | $1,322 | 76 | AbbVie Inc. ($589.09) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/20/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: GI COLON PREP | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Immunology | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $61.33 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 757 | 1,071 | $193,449 | $67,756 |
| 2022 | 7 | 814 | 1,159 | $159,105 | $71,482 |
| 2021 | 5 | 829 | 1,226 | $160,645 | $73,896 |
| 2020 | 4 | 714 | 965 | $126,125 | $46,925 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 478 | 747 | $117,850 | $41,819 | 35.5% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 24 | 67 | $33,596 | $12,540 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 125 | 125 | $24,913 | $8,185 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 68 | $6,580 | $2,160 | 32.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 45 | 45 | $5,842 | $1,527 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 19 | $4,668 | $1,525 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 532 | 848 | $106,000 | $48,647 | 45.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 18 | 47 | $16,920 | $9,126 | 53.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 117 | 117 | $20,475 | $8,223 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 74 | 74 | $5,550 | $2,239 | 40.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 49 | 49 | $5,635 | $2,019 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $1,925 | $958.87 | 49.8% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 13 | 13 | $2,600 | $268.89 | 10.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 549 | 933 | $116,625 | $55,328 | 47.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 143 | 143 | $25,025 | $9,697 | 38.7% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2021 | 11 | 21 | $7,560 | $4,182 | 55.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 82 | 85 | $6,375 | $2,817 | 44.2% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 44 | 44 | $5,060 | $1,872 | 37.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 454 | 705 | $88,125 | $32,891 | 37.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 165 | 165 | $28,875 | $10,691 | 37.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 50 | 50 | $5,750 | $2,250 | 39.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 45 | 45 | $3,375 | $1,094 | 32.4% |
About Tammy Covington, NP-C
Tammy Covington, NP-C is a Family healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2014. The National Provider Identifier (NPI) number assigned to this provider is 1831599893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tammy Covington, NP-C has received a total of $5,500 in payments from pharmaceutical and medical device companies, with $1,922 received in 2024. These payments were reported across 298 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,433).
As a Medicare-enrolled provider, Covington has provided services to 3,114 Medicare beneficiaries, totaling 4,421 services with total Medicare billing of $260,059. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Clermont, FL
- Active Since 08/27/2014
- Last Updated 01/25/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831599893
Products in Payments
- LINZESS (Drug) $583.08
- XELJANZ (Drug) $538.91
- SKYRIZI (Biological) $480.85
- VOQUEZNA (Drug) $393.91
- RINVOQ (Biological) $354.61
- DUPIXENT (Biological) $302.66
- ZENPEP (Drug) $280.54
- HUMIRA (Biological) $242.20
- MAVYRET (Drug) $212.29
- STELARA (Biological) $203.30
- ZEPOSIA (Drug) $167.50
- RELISTOR (Drug) $140.78
- XIFAXAN (Drug) $126.01
- ENTYVIO (Biological) $123.50
- CREON (Drug) $111.98
- IBSRELA (Drug) $101.02
- VIBERZI (Drug) $95.77
- GIMOTI (Drug) $86.40
- DIFICID (Drug) $75.27
- MOTEGRITY (Drug) $68.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clermont
Mrs. Chantal Baptiste, Aprn, APRN
Family — Payments: $13,695
Ashlee Koronka, Aprn, APRN
Family — Payments: $7,969
Jessica Bean, Arnp, ARNP
Family — Payments: $5,976
Mrs. Narissa Seelall, Aprn, APRN
Family — Payments: $5,676
Chelsea Merrow, Aprn, APRN
Family — Payments: $5,044
Adam Figliola, Arnp, Fnp-Bc, ARNP, FNP-BC
Family — Payments: $4,108